Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Application of Microarrays to Neurological Disease

Application of Microarrays to Neurological Disease BASIC SCIENCE SEMINARS IN NEUROLOGY SECTION EDITOR: HASSAN M. FATHALLAH-SHAYKH, MD Lisa-Marie Sturla, PhD; Ana Fernandez-Teijeiro, MD, PhD; Scott L. Pomeroy, MD, PhD odern microarray-based functional genomics holds great promise for revealing novel molecular and cellular mechanisms of disease. First introduced commercially in 1996, microarrays have been used widely to monitor the expression of thousands M of genes in biological samples, as described in the following paragraphs. Other mi- croarray-based genomic applications are also in development, including comparative genomic hy- bridization, on-chip sequencing, and novel drug discovery. For example, DNA array-based com- parative genomic hybridization identifies chromosomal gains and losses with greatly improved resolution compared with conventional methods that use metaphase chromosomes as hybridiza- tion targets. This increase in resolution will continue to improve as the technology advances. More- over, microarrays provide a better platform for automation than is possible with standard meta- phase techniques. Where genetic mutations and aberrations are already well characterized, microarrays 2,3 can be customized to be effectively used as a diagnostic and prognostic tool. In the field of drug discovery, microarrays have the potential to dramatically enhance progress, being used at all stages from target discovery (through validation of new molecular targets and understanding http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Neurology American Medical Association

Application of Microarrays to Neurological Disease

Loading next page...
 
/lp/american-medical-association/application-of-microarrays-to-neurological-disease-qMcXourTf4
Publisher
American Medical Association
Copyright
Copyright 2003 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6149
eISSN
2168-6157
DOI
10.1001/archneur.60.5.676
pmid
12756130
Publisher site
See Article on Publisher Site

Abstract

BASIC SCIENCE SEMINARS IN NEUROLOGY SECTION EDITOR: HASSAN M. FATHALLAH-SHAYKH, MD Lisa-Marie Sturla, PhD; Ana Fernandez-Teijeiro, MD, PhD; Scott L. Pomeroy, MD, PhD odern microarray-based functional genomics holds great promise for revealing novel molecular and cellular mechanisms of disease. First introduced commercially in 1996, microarrays have been used widely to monitor the expression of thousands M of genes in biological samples, as described in the following paragraphs. Other mi- croarray-based genomic applications are also in development, including comparative genomic hy- bridization, on-chip sequencing, and novel drug discovery. For example, DNA array-based com- parative genomic hybridization identifies chromosomal gains and losses with greatly improved resolution compared with conventional methods that use metaphase chromosomes as hybridiza- tion targets. This increase in resolution will continue to improve as the technology advances. More- over, microarrays provide a better platform for automation than is possible with standard meta- phase techniques. Where genetic mutations and aberrations are already well characterized, microarrays 2,3 can be customized to be effectively used as a diagnostic and prognostic tool. In the field of drug discovery, microarrays have the potential to dramatically enhance progress, being used at all stages from target discovery (through validation of new molecular targets and understanding

Journal

JAMA NeurologyAmerican Medical Association

Published: May 1, 2003

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month